Cargando…
Human T Cell Response to Dengue Virus Infection
DENV is a major public health problem worldwide, thus underlining the overall significance of the proposed Program. The four dengue virus (DENV) serotypes (1–4) cause the most common mosquito-borne viral disease of humans, with 3 billion people at risk for infection and up to 100 million cases each...
Autores principales: | Tian, Yuan, Grifoni, Alba, Sette, Alessandro, Weiskopf, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737489/ https://www.ncbi.nlm.nih.gov/pubmed/31552052 http://dx.doi.org/10.3389/fimmu.2019.02125 |
Ejemplares similares
-
T-Cell Immunity to Infection with Dengue Virus in Humans
por: Weiskopf, Daniela, et al.
Publicado: (2014) -
Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection
por: Tian, Yuan, et al.
Publicado: (2016) -
Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design
por: Subramaniam, Krishanthi S., et al.
Publicado: (2020) -
Global Assessment of Dengue Virus-Specific CD4(+) T Cell Responses in Dengue-Endemic Areas
por: Grifoni, Alba, et al.
Publicado: (2017) -
Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection
por: Ansari, Asgar, et al.
Publicado: (2021)